Back to Search
Start Over
Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology
- Source :
- Lancet Infectious Diseases, 21, 12, pp. E364-E374, Lancet Infect Dis, Lancet Infectious Diseases, 21, E364-E374, The Lancet Infectious Diseases, The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2021, 21 (12), pp.e364-e374. ⟨10.1016/S1473-3099(21)00191-2⟩, The Lancet Infectious Diseases, 2021, 21 (12), pp.e364-e374. ⟨10.1016/S1473-3099(21)00191-2⟩, The Lancet. Infectious diseases, vol 21, iss 12
- Publication Year :
- 2021
-
Abstract
- International audience; The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the "One World, One Guideline" initiative of the European Confederation of Medical Mycology. Experts from 23 countries contributed to the development of these guidelines. The aim of this Review is to provide an up-to-date consensus and practical guidance in clinical decision making, by engaging physicians and scientists involved in various aspects of clinical management.
- Subjects :
- medicine.medical_specialty
Consensus
Endemic Diseases
[SDV]Life Sciences [q-bio]
International Cooperation
Clinical Sciences
Clinical Decision-Making
Medizin
MEDLINE
lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]
Guidelines as Topic
Global Health
Microbiology
Article
Histoplasmosis
Vaccine Related
03 medical and health sciences
0302 clinical medicine
All institutes and research themes of the Radboud University Medical Center
Risk Factors
Biodefense
Mycology
Epidemiology
medicine
Animals
Humans
030212 general & internal medicine
Intensive care medicine
0303 health sciences
Sporotrichosis
030306 microbiology
Paracoccidioidomycosis
business.industry
Prevention
Guideline
medicine.disease
3. Good health
Europe
Emerging Infectious Diseases
Good Health and Well Being
Infectious Diseases
Mycoses
Medical Microbiology
Public Health and Health Services
Infection
business
Blastomycosis
Subjects
Details
- ISSN :
- 14733099 and 14744457
- Database :
- OpenAIRE
- Journal :
- Lancet Infectious Diseases, 21, 12, pp. E364-E374, Lancet Infect Dis, Lancet Infectious Diseases, 21, E364-E374, The Lancet Infectious Diseases, The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2021, 21 (12), pp.e364-e374. ⟨10.1016/S1473-3099(21)00191-2⟩, The Lancet Infectious Diseases, 2021, 21 (12), pp.e364-e374. ⟨10.1016/S1473-3099(21)00191-2⟩, The Lancet. Infectious diseases, vol 21, iss 12
- Accession number :
- edsair.doi.dedup.....fdbe20fb2a2e62c2b427cd4a54dfcedd